472 related articles for article (PubMed ID: 22198208)
1. Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research.
Ivashkevich A; Redon CE; Nakamura AJ; Martin RF; Martin OA
Cancer Lett; 2012 Dec; 327(1-2):123-33. PubMed ID: 22198208
[TBL] [Abstract][Full Text] [Related]
2. Development of a high-throughput γ-H2AX assay based on imaging flow cytometry.
Lee Y; Wang Q; Shuryak I; Brenner DJ; Turner HC
Radiat Oncol; 2019 Aug; 14(1):150. PubMed ID: 31438980
[TBL] [Abstract][Full Text] [Related]
3. Predicting Radiosensitivity with Gamma-H2AX Foci Assay after Single High-Dose-Rate and Pulsed Dose-Rate Ionizing Irradiation.
van Oorschot B; Hovingh S; Dekker A; Stalpers LJ; Franken NA
Radiat Res; 2016 Feb; 185(2):190-8. PubMed ID: 26789702
[TBL] [Abstract][Full Text] [Related]
4. γ-H2AX and other histone post-translational modifications in the clinic.
Redon CE; Weyemi U; Parekh PR; Huang D; Burrell AS; Bonner WM
Biochim Biophys Acta; 2012 Jul; 1819(7):743-56. PubMed ID: 22430255
[TBL] [Abstract][Full Text] [Related]
5. Low-dose hyper-radiosensitivity is not caused by a failure to recognize DNA double-strand breaks.
Wykes SM; Piasentin E; Joiner MC; Wilson GD; Marples B
Radiat Res; 2006 May; 165(5):516-24. PubMed ID: 16669705
[TBL] [Abstract][Full Text] [Related]
6. Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.
Lobachevsky P; Leong T; Daly P; Smith J; Best N; Tomaszewski J; Thompson ER; Li N; Campbell IG; Martin RF; Martin OA
Cancer Lett; 2016 Dec; 383(2):212-219. PubMed ID: 27693457
[TBL] [Abstract][Full Text] [Related]
7. High throughput measurement of γH2AX DSB repair kinetics in a healthy human population.
Sharma PM; Ponnaiya B; Taveras M; Shuryak I; Turner H; Brenner DJ
PLoS One; 2015; 10(3):e0121083. PubMed ID: 25794041
[TBL] [Abstract][Full Text] [Related]
8. Targeting BRG1 chromatin remodeler via its bromodomain for enhanced tumor cell radiosensitivity in vitro and in vivo.
Kwon SJ; Lee SK; Na J; Lee SA; Lee HS; Park JH; Chung JK; Youn H; Kwon J
Mol Cancer Ther; 2015 Feb; 14(2):597-607. PubMed ID: 25504753
[TBL] [Abstract][Full Text] [Related]
9. Biodosimetry Based on γ-H2AX Quantification and Cytogenetics after Partial- and Total-Body Irradiation during Fractionated Radiotherapy.
Zahnreich S; Ebersberger A; Kaina B; Schmidberger H
Radiat Res; 2015 Apr; 183(4):432-46. PubMed ID: 25844946
[TBL] [Abstract][Full Text] [Related]
10. Gamma histone 2AX (γ-H2AX)as a predictive tool in radiation oncology.
Pouliliou S; Koukourakis MI
Biomarkers; 2014 May; 19(3):167-80. PubMed ID: 24611829
[TBL] [Abstract][Full Text] [Related]
11. Gamma-H2AX - a novel biomarker for DNA double-strand breaks.
Kuo LJ; Yang LX
In Vivo; 2008; 22(3):305-9. PubMed ID: 18610740
[TBL] [Abstract][Full Text] [Related]
12. Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment.
Bourton EC; Plowman PN; Smith D; Arlett CF; Parris CN
Int J Cancer; 2011 Dec; 129(12):2928-34. PubMed ID: 21491423
[TBL] [Abstract][Full Text] [Related]
13. Statistical analysis of kinetics, distribution and co-localisation of DNA repair foci in irradiated cells: cell cycle effect and implications for prediction of radiosensitivity.
Martin OA; Ivashkevich A; Choo S; Woodbine L; Jeggo PA; Martin RF; Lobachevsky P
DNA Repair (Amst); 2013 Oct; 12(10):844-55. PubMed ID: 23891250
[TBL] [Abstract][Full Text] [Related]
14. gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy.
Kao J; Milano MT; Javaheri A; Garofalo MC; Chmura SJ; Weichselbaum RR; Kron SJ
Curr Cancer Drug Targets; 2006 May; 6(3):197-205. PubMed ID: 16712457
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci.
Djuzenova CS; Elsner I; Katzer A; Worschech E; Distel LV; Flentje M; Polat B
Radiat Oncol; 2013 Apr; 8():98. PubMed ID: 23617930
[TBL] [Abstract][Full Text] [Related]
16. In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer.
Lassmann M; Hänscheid H; Gassen D; Biko J; Meineke V; Reiners C; Scherthan H
J Nucl Med; 2010 Aug; 51(8):1318-25. PubMed ID: 20660387
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in the use of γ-H2AX as a quantitative DNA double-strand break biomarker.
Redon CE; Nakamura AJ; Martin OA; Parekh PR; Weyemi US; Bonner WM
Aging (Albany NY); 2011 Feb; 3(2):168-74. PubMed ID: 21325706
[TBL] [Abstract][Full Text] [Related]
18. Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity.
Mirzayans R; Severin D; Murray D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1498-505. PubMed ID: 17126209
[TBL] [Abstract][Full Text] [Related]
19. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
20. H2AX phosphorylation screen of cells from radiosensitive cancer patients reveals a novel DNA double-strand break repair cellular phenotype.
Vasireddy RS; Sprung CN; Cempaka NL; Chao M; McKay MJ
Br J Cancer; 2010 May; 102(10):1511-8. PubMed ID: 20461094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
